BASIC RESEARCH GROUP CORE 006 ? GENOMIC SCIENCES SHARED RESOURCES PROJECT SUMMARY/ABSTRACT The Genomic Sciences Shared Resource (GSSR) provides advanced genomics technologies required to support the full range of cancer research conducted by Vanderbilt-Ingram Cancer Center (VICC) members. This facility provides investigators with state-of-the-art services utilizing a myriad of genotyping and sequencing technology platforms. A unique feature of the facility is the availability and customizability of numerous major genomics technology platforms, which offer exceptional flexibility in analytical approaches. The GSSR service lines include genotyping, high-throughput genotyping, Sanger sequencing and ?next-generation? sequencing, including whole genome, whole exome, targeted re-sequencing, RNA-seq, ChIP-seq and miR-seq. The GSSR also works with investigators to aid in the development of new sequencing strategies such as PRO-seq (precision global nuclear run-on-sequencing) and ChIP-Exo (chromatin immunoprecipitation + exonuclease footprinting-sequencing). As these technologies and standards evolve, the GSSR continues to update capabilities to stay at the forefront of these fields. The resource maintains a bevy of state-of-the-art instruments, including two HiSeq 2500 sequencers, two MiSeq sequencers and links to the advanced computing cluster. Typically, one of the HiSeq instruments is assigned to conventional run mode to accomplish requests such as large exome projects, while the second instrument is used in rapid run mode to facilitate very rapid turnover of smaller projects, most commonly RNA-Seq analysis. The GSSR provides a high level of training and consultation for users of all levels, including providing ?studios? to review cancer-related projects from investigators seeking to use technologies in this resource. Thus, each project receives custom review and input from a highly experienced staff. Storage of data and access to data is paramount in this area, and the GSSR has fully integrated into the institution?s data center and supercomputing cluster to enable rapid and efficient transfer and analysis of data. Data generation is only the first step to a successful experiment and investigators have varying levels of sophistication in the area of data analysis. The GSSR provides essentially raw data (following QC processes to ensure quality) to sophisticated user groups, but also provides data sets with a significant amount of standard analysis to many groups. Access for users to workstations, a large panel of commercial analytical tools and orientation to the uses of these tools is also provided. Most importantly, the GSSR shares a bioinformatician and data manager with the Quantitative Sciences Shared Resource (QSSR); staff are housed in the GSSR to provide investigators with personalized guidance for data analysis and to interface with the advanced analytical services provided by the QSSR when customized analysis is needed.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-21
Application #
9152300
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Program Officer
Marino, Michael A
Project Start
Project End
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
21
Fiscal Year
2016
Total Cost
$291,256
Indirect Cost
$105,743
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Pannala, Venkat R; Wall, Martha L; Estes, Shanea K et al. (2018) Metabolic network-based predictions of toxicant-induced metabolite changes in the laboratory rat. Sci Rep 8:11678
Zhao, Shilin; Li, Chung-I; Guo, Yan et al. (2018) RnaSeqSampleSize: real data based sample size estimation for RNA sequencing. BMC Bioinformatics 19:191
Croessmann, Sarah; Sheehan, Jonathan H; Lee, Kyung-Min et al. (2018) PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K? Inhibitors. Clin Cancer Res 24:1426-1435
Doxie, Deon B; Greenplate, Allison R; Gandelman, Jocelyn S et al. (2018) BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors. Pigment Cell Melanoma Res 31:708-719
Salisbury-Ruf, Christi T; Bertram, Clinton C; Vergeade, Aurelia et al. (2018) Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study. Elife 7:
Laroumanie, Fanny; Korneva, Arina; Bersi, Matthew R et al. (2018) LNK deficiency promotes acute aortic dissection and rupture. JCI Insight 3:
Burns, Michael C; Howes, Jennifer E; Sun, Qi et al. (2018) High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling. Anal Biochem 548:44-52
Phelps, Hannah M; Al-Jadiry, Mazin F; Corbitt, Natasha M et al. (2018) Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq. World J Pediatr 14:585-593
Liu, Qi; Herring, Charles A; Sheng, Quanhu et al. (2018) Quantitative assessment of cell population diversity in single-cell landscapes. PLoS Biol 16:e2006687
Almodovar, Karinna; Iams, Wade T; Meador, Catherine B et al. (2018) Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse. J Thorac Oncol 13:112-123

Showing the most recent 10 out of 2462 publications